Expression profiling of Epstein-Barr virus-derived microRNA in systemic chronic active EBV disease

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Systemic chronic active Epstein-Barr virus disease (sCAEBV) is a severe condition driven by EBV-infected T and NK cells.
• This disease leads to systemic inflammation and can progress to hemophagocytic lymphohistiocytosis (HLH).
• Epstein-Barr virus (EBV) encodes microRNAs (miRNAs) known as miR-BARTs, implicated in other EBV-associated conditions.

Purpose of the Study:

• To investigate the expression and role of miR-BARTs in systemic chronic active Epstein-Barr virus disease (sCAEBV).
• To determine if specific miR-BARTs are associated with disease progression and inflammation in sCAEBV patients.

Main Methods:

• Analysis of miR-BART expression in EBV-infected T/NK cell lines and primary cells from sCAEBV patients.
• Sequence analysis of the EBV genome regions encoding miR-BARTs.
• Functional studies involving inhibition of miR-BART7-3p to assess its impact on immune gene expression.
• Detection of miR-BARTs in patient plasma and spleen tissue.

Main Results:

• miR-BARTs were highly expressed in sCAEBV-derived cell lines and patient cells, with miR-BART7-3p showing the highest levels.
• No deletions were found in the EBV genome encoding miR-BARTs.
• Inhibition of miR-BART7-3p affected immune-related gene expression in sCAEBV cells.
• miR-BARTs, particularly miR-BART7-3p, were detected in plasma and spleen macrophages of sCAEBV patients.

Conclusions:

• miR-BARTs are abundantly expressed and secreted by EBV-infected cells in sCAEBV.
• Secreted miR-BARTs, potentially miR-BART7-3p, may be internalized by monocytes, influencing their function and contributing to sCAEBV pathogenesis.
• Further research is warranted to fully elucidate the mechanisms of miR-BARTs in sCAEBV.